News
ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs ...
The Uttarakhand Special Task Force arrested Devi Dayal Gupta for manufacturing fake medicines in his factory, mimicking top pharmaceutical companies' products. The accused, along with three others, ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
DEHRADUN: In a significant breakthrough, the Uttarakhand Police’s Special Task Force (STF) has arrested the alleged ...
India and the US are key trade partners, but a formal trade deal is still missing. As talks progress, the big question is: ...
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
Sudip Bandyopadhyay of Inditrade Capital discusses the positive outlook for the Indian pharma sector following the easing of tariff concerns. He highlights Sun Pharma's promising developments and ...
ICICI Securities recommended hold rating on Polycab India with a target price of Rs 7000 in its research report dated July 18 ...
The ministry of electronics and information technology (MeitY), under its Digital India Mission, proposes to provide training ...
A settlement between Philips and Transsion and a loss for AstraZeneca in the UK were also among the top talking points ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results